Development, characterization and in vivo evaluation of Tolvaptan solid dispersions via solvent evaporation technique

Authors

  • Ramesh K NTUH, Kukatpally, Hyderabad - 500072, Telangana, India
  • Chandra Shekar B Bomma Institute of Pharmacy, Allipuram, Khammam - 507318, Telangana, India.
  • Khadgapathi P Hetero Labs Ltd, Hyderabad - 500055, Telangana, India.
  • Bhikshapathi D.V.R.N Vijaya College of Pharmacy, Hayath Nagar, Hyderabad - 501511, Telangana, India.
  • Renuka K Vijaya College of Pharmacy, Hayath Nagar, Hyderabad - 501511, Telangana, India.

Keywords:

Tolvaptan, hydrophilic carriers, solvent evaporation technique, solubility, solid dispersions

Abstract

Investigation on in vitro and in vivo behavior of solid dispersions containing Tolvaptan is the focus of the present research work. The effect of various hydrophilic polymers on the aqueous solubility was studied. Kleptose HPB was selected as carrier and solid dispersions were prepared by solvent evaporation technique. Evaluation of solid dispersion for percentage yield, drug content and solubility was most appropriate. Solid dispersions of drug: Kleptose HPB: SLS (1:2:1 ratio) (SE8) shown higher dissolution rate i.e. 96.8 % compared with and pure drug (39.6%) and other formulations. Differential scanning calorimetry and powder X-ray diffraction performed on solid dispersion showed that Tolvaptan existed in the amorphous form within the solid dispersion formulation fabricated using the solvent evaporation process. Additionally, scanning electron microscopy studies suggested the conversion of crystalline Tolvaptan to an amorphous form. In vivo studies of pure drug and optimized formulation (SE8) were carried out in male Wistar rats and pharmacokinetic parameters calculated using Kinetica software 2000. In vivo studies revealed that a marked increase in dissolution and bioavailability was exhibited by optimized Tolvaptan solid dispersion (SE8). AUC (0-t) was increased more than 2.11 folds, Cmax increased about 2.67 folds and tmax reduced by 1 hour, when compared to the pure drug. Thus, the study has illustrated the potential use of a solid dispersion system for the delivery of a very poorly soluble drug tolvaptan with a better bioavailability. Therefore, the solid dispersions prepared by solvent evaporation method using Kleptose HPB as hydrophilic carrier can be successfully used for improvement of dissolution of Tolvaptan and resulted in faster onset of action as indicated by in vivo studies.

References

. Wagh VT, Jagtap VA, Shaikh TJ, Nandedkar SY. Formulation and Evaluation of Glimepiride Solid Dispersion Tablets for Their Solubility Enhancement. J. Adv Sci Res. 2012; 3(4): 36-41.

. Bhaskar D, Rama Rao T. Formulation and in vitro evaluation of flurbiprofen-polyethylene glycol 20000 solid dispersions. J. Applied Pharm Sci. 2014; 4 (07): 76-81.

. Sameer Singh, Raviraj Singh B, Lalit Yadav. A review on solid dispersion. Int. J. pharm. & Life sci. 2011; 2(9): 1078-1095.

. Deepthi Naidu K, Prasanna Lakshmi A, Ajay Kumar B, Narandra Reddy J. Formulation and In-vitro evaluation of conventional tablets of Ezetimibe by using Solid Dispersion. . Int J Pharm Pharm Sci. 2013; 5 (2): 331-335.

. Sree Giri Prasad B, Gupta VRM, Vijaya K, Tamilselvan A, Siva Subramanian N. Formulation and evaluation of fast dissolving tablet of Tolvaptan. JGTPS. 2015; 6(1): 2403 – 2410.

. Dongqing J. Progress of clinical studies, tolvaptan. J Clinical Res Adva in Clinical Use of Drugs Abroad. 2014; 03: 176-178.

. Xiaogao Z, Shengjun Z. Bioequivalence Study of Two 30 Mg Tolvaptan Tablets Formulations in Healthy Chinese under Fed Condition. J Bioequiv Availab. 2014; 6: 181-185.

. Higuchi T, Connors KA .Phase solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–122.

. AppaRao B, Shivalingam M. R, Kishore Reddy Y. V, Soma sekhara Rao, Rajesh K, Sunitha N. Formulation and Evaluation of Aceclofenac Solid Dispersions for Dissolution Rate Enhancement. Int J Pharma Sci and Drug Res. 2010; 2(2): 146-150.

. Higuchi T, Connors KA. Phase solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–122.

. Mayur Chaudhari D, Raju Sonawane O, Laxmikant Z, Sasmita Nayak, Sanjay Bari B. Solubility and dissolution enhancement of poorly water soluble Glimepiride by using solid dispersion technique. . Int J Pharm Pharm Sci. 2012; 4(5): 534-539.

. Prasanna Kumari J, Ramarao T, Jayaveera K N, Bikshapathi D V R N, Madhusudan Rao Y. Design and In vivo evaluation of Metoprolol Tartrate bilayer floating tablets in healthy human volunteers. IJDD. 2014; 6: 14-23.

. Ramesh K, Chandra Shekar B, Khadgapathi P. Formulation and evaluation of poorly soluble Etravirine by spray drying method. . Int J Pharm Pharm Sci. 2015; 7(4): 98 – 103.

. Ritesh F, Purnima A. Development and evaluation of Lafutidine solid dispersion via hot melt extrusion: Investigating drug-polymer miscibility with advanced characterization. Asian J Pharma Sci. 2014; 9(2): 92-106.

. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm. 2002; 54: 107–117.

. Kalyana Chakravarthy V, Gowri Shankar D. Development and validation of RP- HPLC method for estimation of tolvaptan in bulk and its Pharmaceutical formulation. RJC. 2011; 4 (1): 165-171.

Downloads

Published

2015-03-31

How to Cite

Ramesh K, Chandra Shekar B, Khadgapathi P, Bhikshapathi D.V.R.N, & Renuka K. (2015). Development, characterization and in vivo evaluation of Tolvaptan solid dispersions via solvent evaporation technique. International Journal of Drug Delivery, 7(1), 32–43. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/269

Issue

Section

Original Research Articles